STRONGYLOIDIASIS

This adverse event was reported 750 times

These drugs are most commonly taken by patients reporting STRONGYLOIDIASIS:

# Drug Count
0 PREDNISONE 213
1 TACROLIMUS 176
2 PREDNISOLONE 164
3 TACROLIMUS CAPSULES 151
4 MYCOPHENOLATE MOFETIL 129
5 DEXAMETHASONE 118
6 DEXAMETHASONE 1.5 MG 103
7 METHYLPREDNISOLONE 92
8 CYCLOPHOSPHAMIDE 69
9 METHOTREXATE SODIUM 55
See all common drugs associated with STRONGYLOIDIASIS

STRONGYLOIDIASIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ALBENDAZOLE 30 0.0290
1 IVERMECTIN 54 0.0195
2 PREDNISOLONE SODIUM PHOSPHATE 11 0.0084
3 BASILIXIMAB 34 0.0067
4 PYRIDOSTIGMINE BROMIDE ORAL 4 0.0054
5 TACROLIMUS CAPSULES 151 0.0040
6 VASOPRESSIN 4 0.0038
7 MYCOPHENILIC ACID 13 0.0035
8 PYRIMETHAMINE 2 0.0035
9 AMPICILLIN INJECTION 10 0.0030
See all drugs enriched for association with STRONGYLOIDIASIS

STRONGYLOIDIASIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Tetracycline-class Drug [EPC] 1 0.0000
1 Nonsteroidal Anti-inflammatory Drug [EPC] 25 0.0000
2 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
3 Insulin Analog [EPC] 1 0.0000
See all drug classes enriched for association with STRONGYLOIDIASIS